Anti–Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation
Open Access
- 1 August 2016
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 16 (8) , 2483-2486
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- ABO Incompatible Renal Transplantation Without Antibody Removal Using Conventional Immunosuppression AloneAmerican Journal of Transplantation, 2014
- Anti-A and anti-B haemagglutinin levels in intravenous immunoglobulins: Are they on the rise? A comparison of four different analysis methods and six productsBiologicals, 2014
- Outcome of Desensitization in Human Leukocyte Antigen– and ABO-Incompatible Living Donor Kidney Transplantation: A Single-Center Experience in More Than 100 PatientsTransplantation Proceedings, 2013
- Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchangeImmunologic Research, 2010
- ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad ImplementationTransplantation, 2009
- The critical role of plasmapheresis in ABO‐incompatible renal transplantationTransfusion, 2008
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal TransplantationNew England Journal of Medicine, 2008
- ABO Incompatible High‐Titer Renal Transplantation without Splenectomy or Anti‐CD20 TreatmentAmerican Journal of Transplantation, 2005
- Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without SplenectomyAmerican Journal of Transplantation, 2004
- RENAL TRANSPLANT IN A PATIENT WITH MAJOR DONOR-RECIPIENT BLOOD GROUP INCOMPATIBILITYTransplantation, 1981